Literature DB >> 15898991

Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.

T Sone1, K Dairiki, K Morikubo, K Shimizu, H Tsunoo, T Mori, K Kino.   

Abstract

BACKGROUND: Pollens from species of Cupressaceae family are one of the most important causes of respiratory allergies worldwide. In Japan, many patients with pollinosis have specific IgE to both pollens of Japanese cypress (Chamaecyparis obtusa) and Japanese cedar (Cryptomeria japonica). The sequences between Cha o 1 and Cry j 1, the major allergens of Japanese cypress and Japanese cedar pollens, respectively, are 80% identical.
OBJECTIVE: This study was undertaken to identify T cell epitopes in Cha o 1, and to elucidate the mechanism of cross-allergenicity between Cha o 1 and Cry j 1, at the T cell level.
METHODS: T cell epitopes in Cha o 1 were identified by the reactivity of T cell lines, generated from 19 patients, to stimulation with overlapping peptides. The subsets of T cell clones specific to rCha o 1 were determined according to their ability to produce IL-4 and IFN-gamma. Peptide specificities of two T cell clones were determined by stimulation with the peptides from Cha o 1 and Cry j 1.
RESULTS: Four dominant and six subdominant T cell epitopes were identified in Cha o 1. While four T cell epitopes, p11-30, p211-230, p251-270 and p331-350, were common to Cha o 1 and Cry j 1, 4 T cell epitopes, p61-80, p71-90, p311-330 and p321-340, were considered to be unique to Cha o 1. The subsets of T cell clones were predominantly of T helper2-type. One T cell clone recognized p16-30, which is common to Cha o 1 and Cry j 1, but another recognized p321-330, which is unique to Cha o 1.
CONCLUSION: Presence of both T cells reactive to T cell epitopes common to Cha o 1 and Cry j 1 and T cells specific to T cell epitopes unique to Cha o 1 in patients with pollinosis contributes to prolonged symptoms after the cedar pollen season in March and the following cypress pollen season in April.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15898991     DOI: 10.1111/j.1365-2222.2005.02221.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

1.  Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies.

Authors:  Fumio Takaiwa; Lijun Yang
Journal:  Transgenic Res       Date:  2014-03-18       Impact factor: 2.788

2.  Characteristic motifs for families of allergenic proteins.

Authors:  Ovidiu Ivanciuc; Tzintzuni Garcia; Miguel Torres; Catherine H Schein; Werner Braun
Journal:  Mol Immunol       Date:  2008-10-31       Impact factor: 4.407

3.  An aerobiological perspective in allergy and asthma.

Authors:  Anand Bahadur Singh; Chandni Mathur
Journal:  Asia Pac Allergy       Date:  2012-07-25

Review 4.  Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.

Authors:  S R Prickett; J M Rolland; R E O'Hehir
Journal:  Clin Exp Allergy       Date:  2015-06       Impact factor: 5.018

5.  Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure.

Authors:  Sho Kanzaki; Kazuhiro Hashiguchi; Ken-Ichiro Wakabayashi; Kiyochika Suematsu; Kimihiro Okubo
Journal:  J Drug Assess       Date:  2016-09-27

6.  Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study.

Authors:  Yan Su; Eliezer Romeu-Bonilla; Athanasia Anagnostou; David Fitz-Patrick; William Hearl; Teri Heiland
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

7.  Safety and efficacy of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a randomized controlled trial.

Authors:  Daisuke Murakami; Motohiro Sawatsubashi; Hirofumi Omori; Akira Saito; Akio Kato; Shizuo Komune; Takashi Nakagawa
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

8.  T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.

Authors:  Shinya Takaishi; Saburo Saito; Tomonori Endo; Daiya Asaka; Yuhya Wakasa; Hidenori Takagi; Kenjiro Ozawa; Fumio Takaiwa; Nobuyoshi Otori; Hiromi Kojima
Journal:  Immunology       Date:  2019-08-23       Impact factor: 7.397

Review 9.  T Cell Epitope Peptide Therapy for Allergic Diseases.

Authors:  Robyn E O'Hehir; Sara R Prickett; Jennifer M Rolland
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

10.  Predicting HLA CD4 Immunogenicity in Human Populations.

Authors:  Sandeep Kumar Dhanda; Edita Karosiene; Lindy Edwards; Alba Grifoni; Sinu Paul; Massimo Andreatta; Daniela Weiskopf; John Sidney; Morten Nielsen; Bjoern Peters; Alessandro Sette
Journal:  Front Immunol       Date:  2018-06-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.